Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Travere Therapeutics Inc (TVTX)

Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Travere Therapeutics Inc 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 USA

https://travere.com P: 888-969-7879

Description:

Travere Therapeutics Inc. is a biopharmaceutical company. It engages to identify, develop and deliver life-changing therapies. Travere Therapeutics Inc., formerly known as Retrophin Inc., is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 1,096,257
Enterprise Value, $K 1,038,077
Shares Outstanding, K 76,129
Annual Sales, $ 145,240 K
Annual Net Income, $ -111,400 K
Last Quarter Sales, $ 54,120 K
Last Quarter Net Income, $ -70,410 K
EBIT, $ -417,660 K
EBITDA, $ -384,870 K
60-Month Beta 0.71
% of Insider Shareholders 3.75%
Float, K 73,274
% Float 96.25%
Short Volume Ratio 0.27

Growth:

1-Year Return 7.01%
3-Year Return -41.74%
5-Year Return 20.79%
5-Year Revenue Growth -11.57%
5-Year Earnings Growth -99.61%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.90 on 08/01/24
Next Earnings Date 11/05/24
Earnings Per Share ttm -4.99
EPS Growth vs. Prev Qtr 48.86%
EPS Growth vs. Prev Year 20.35%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TVTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -269.18%
Return-on-Assets % -54.07%
Profit Margin % -76.70%
Debt/Equity 0.00
Price/Sales 7.52
Price/Cash Flow N/A
Price/Book 68.07
Book Value/Share 0.20
Interest Coverage -32.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar